SMART Control stents in femoropopliteal region
Introduction/Aim. Occlusive disease of lower limb arteries have been so far traditionally best treated with bypass surgery, but we want to find minimally invasive approach that should be at least as good as conventional surgery, and hopefully better. The aim of this study was to evaluate SMART Contr...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Military Health Department, Ministry of Defance, Serbia
2008-01-01
|
| Series: | Vojnosanitetski Pregled |
| Subjects: | |
| Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2008/0042-84500812871J.pdf |
| _version_ | 1818562667140349952 |
|---|---|
| author | Jagić Nikola Stamenković Dragan Tončev Slavko Petrović Dejan Miloradović Vladimir Miličić Biljana |
| author_facet | Jagić Nikola Stamenković Dragan Tončev Slavko Petrović Dejan Miloradović Vladimir Miličić Biljana |
| author_sort | Jagić Nikola |
| collection | DOAJ |
| description | Introduction/Aim. Occlusive disease of lower limb arteries have been so far traditionally best treated with bypass surgery, but we want to find minimally invasive approach that should be at least as good as conventional surgery, and hopefully better. The aim of this study was to evaluate SMART Control stents (Cordis, J&J) in Trans Atlantic Society Consensus (TASC) B and C femoropopliteal lesions during one-year follow-up. Methods. Retrospective nonrandomized analysis included forty arteries in consecutive 40 patients who were stented with SMART Control stents. Primary patency at 12-month verified with Duplex Ultrasound and Acute Brachial Index (ABI) as well as freedom from Target Vessel Revascularization (TVR) were primary endpoints. Results. Primary technical success at stent implantation was 100%. Mean ABI values were preprocedurally 0.50, postprocedurally 0.83, at one month 0.86, at six months 0.84, at one year 0.78. After one year 39 stents were patent (97.5%). Conclusion. Excellent performance of the stent from technical point of view and a midterm results in vessel patency, as well as the absence of need for TVR were achieved. Yet, life expectancy in this cohort group of patients demands longer follow up data to draw a definite sustained positive conclusion. |
| first_indexed | 2024-12-14T01:06:46Z |
| format | Article |
| id | doaj.art-66a98134ffd94bd380c5e8cce3143797 |
| institution | Directory Open Access Journal |
| issn | 0042-8450 |
| language | English |
| last_indexed | 2024-12-14T01:06:46Z |
| publishDate | 2008-01-01 |
| publisher | Military Health Department, Ministry of Defance, Serbia |
| record_format | Article |
| series | Vojnosanitetski Pregled |
| spelling | doaj.art-66a98134ffd94bd380c5e8cce31437972022-12-21T23:22:57ZengMilitary Health Department, Ministry of Defance, SerbiaVojnosanitetski Pregled0042-84502008-01-01651287187510.2298/VSP0812871JSMART Control stents in femoropopliteal regionJagić NikolaStamenković DraganTončev SlavkoPetrović DejanMiloradović VladimirMiličić BiljanaIntroduction/Aim. Occlusive disease of lower limb arteries have been so far traditionally best treated with bypass surgery, but we want to find minimally invasive approach that should be at least as good as conventional surgery, and hopefully better. The aim of this study was to evaluate SMART Control stents (Cordis, J&J) in Trans Atlantic Society Consensus (TASC) B and C femoropopliteal lesions during one-year follow-up. Methods. Retrospective nonrandomized analysis included forty arteries in consecutive 40 patients who were stented with SMART Control stents. Primary patency at 12-month verified with Duplex Ultrasound and Acute Brachial Index (ABI) as well as freedom from Target Vessel Revascularization (TVR) were primary endpoints. Results. Primary technical success at stent implantation was 100%. Mean ABI values were preprocedurally 0.50, postprocedurally 0.83, at one month 0.86, at six months 0.84, at one year 0.78. After one year 39 stents were patent (97.5%). Conclusion. Excellent performance of the stent from technical point of view and a midterm results in vessel patency, as well as the absence of need for TVR were achieved. Yet, life expectancy in this cohort group of patients demands longer follow up data to draw a definite sustained positive conclusion.http://www.doiserbia.nb.rs/img/doi/0042-8450/2008/0042-84500812871J.pdffemoral arteryarterial occlusive diseasesstentsprognosis |
| spellingShingle | Jagić Nikola Stamenković Dragan Tončev Slavko Petrović Dejan Miloradović Vladimir Miličić Biljana SMART Control stents in femoropopliteal region Vojnosanitetski Pregled femoral artery arterial occlusive diseases stents prognosis |
| title | SMART Control stents in femoropopliteal region |
| title_full | SMART Control stents in femoropopliteal region |
| title_fullStr | SMART Control stents in femoropopliteal region |
| title_full_unstemmed | SMART Control stents in femoropopliteal region |
| title_short | SMART Control stents in femoropopliteal region |
| title_sort | smart control stents in femoropopliteal region |
| topic | femoral artery arterial occlusive diseases stents prognosis |
| url | http://www.doiserbia.nb.rs/img/doi/0042-8450/2008/0042-84500812871J.pdf |
| work_keys_str_mv | AT jagicnikola smartcontrolstentsinfemoropoplitealregion AT stamenkovicdragan smartcontrolstentsinfemoropoplitealregion AT toncevslavko smartcontrolstentsinfemoropoplitealregion AT petrovicdejan smartcontrolstentsinfemoropoplitealregion AT miloradovicvladimir smartcontrolstentsinfemoropoplitealregion AT milicicbiljana smartcontrolstentsinfemoropoplitealregion |